A miR-centric view of head and neck cancers
- PMID: 21549178
- DOI: 10.1016/j.bbcan.2011.04.003
A miR-centric view of head and neck cancers
Abstract
Head and Neck Squamous Cell Carcinomas (HNSCCs) constitute the sixth most common cancer worldwide with an average 5-year survival rate of around 50%. Several microRNAs, small non-coding RNAs involved in post-transcriptional gene regulation, have been linked to HNSCC based on their differential expression in tumors. Here, we present a compilation of multiple types of information on each HNSCC linked miRNA including their expression status in tumors, their molecular targets relevant to cancer, results of gene manipulation studies and association with clinical outcome. Further, we use this information to devise a new scheme for classifying them into causal and non-causal miRNAs in HNSCC. We also discuss the possibility of using miRNAs as prognostic and diagnostic biomarkers for HNSCC, based on existing literature. Finally, we present available evidence that shows how altered expression of specific miRNAs can contribute to various "hallmarks of cancer" phenotypes such as limitless replicative potential owing to abnormal cell cycle regulation, evasion of apoptosis, reduced response to anti-growth signals, and Epithelial-Mesechymal transition (EMT).
2011 Elsevier B.V. All rights reserved.
Similar articles
-
Role of miRNA in head and neck squamous cell carcinoma.Expert Rev Anticancer Ther. 2015 Feb;15(2):183-97. doi: 10.1586/14737140.2015.978294. Epub 2014 Nov 4. Expert Rev Anticancer Ther. 2015. PMID: 25367254 Review.
-
MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.Cancer Biomark. 2015;15(3):213-8. doi: 10.3233/CBM-150464. Cancer Biomark. 2015. PMID: 25769448 Review.
-
Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.Head Neck. 2016 Apr;38(4):522-8. doi: 10.1002/hed.23912. Epub 2015 Jun 16. Head Neck. 2016. PMID: 25351569
-
Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review.Oral Dis. 2018 Nov;24(8):1417-1427. doi: 10.1111/odi.12782. Epub 2017 Nov 3. Oral Dis. 2018. PMID: 28941018 Review.
-
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.Oncol Rep. 2016 Jun;35(6):3321-30. doi: 10.3892/or.2016.4698. Epub 2016 Mar 23. Oncol Rep. 2016. PMID: 27035560
Cited by
-
New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas.Front Oncol. 2012 Apr 11;2:36. doi: 10.3389/fonc.2012.00036. eCollection 2012. Front Oncol. 2012. PMID: 22655271 Free PMC article.
-
Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer.PLoS One. 2012;7(6):e38711. doi: 10.1371/journal.pone.0038711. Epub 2012 Jun 12. PLoS One. 2012. PMID: 22701698 Free PMC article.
-
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies.Transl Cancer Res. 2021 Jun;10(6):3090-3110. doi: 10.21037/tcr-20-2530. Transl Cancer Res. 2021. PMID: 35116619 Free PMC article. Review.
-
Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.Int J Mol Sci. 2020 May 24;21(10):3693. doi: 10.3390/ijms21103693. Int J Mol Sci. 2020. PMID: 32456271 Free PMC article. Review.
-
Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.Mol Cancer. 2015 Feb 15;14:42. doi: 10.1186/s12943-015-0299-z. Mol Cancer. 2015. PMID: 25743594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources